Literature DB >> 3285211

Current concepts. Treatment of infections associated with human immunodeficiency virus.

A E Glatt1, K Chirgwin, S H Landesman.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3285211     DOI: 10.1056/NEJM198806023182206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum.

Authors:  J M Bjorneby; B D Hunsaker; M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 2.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 3.  Drug treatment of pneumonia in the hospital. What are the choices?

Authors:  M Aoun; J Klastersky
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

4.  Compliance and laboratory data predict relapse rate of Pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine.

Authors:  M Opravil; R Weber; B Ledergerber; R Speich; W Siegenthaler; R Lüthy
Journal:  Klin Wochenschr       Date:  1990-04-17

Review 5.  AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.

Authors:  A J Pinching
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

6.  Early HIV detection: a community mental health role.

Authors:  M D Knox; C F Clark
Journal:  J Ment Health Adm       Date:  1991

Review 7.  HIV: treating Pneumocystis pneumonia (PCP).

Authors:  Richard John Bellamy
Journal:  BMJ Clin Evid       Date:  2008-07-16

8.  Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine.

Authors:  S Köppen; T Grünewald; G Jautzke; J Gottschalk; H D Pohle; B Ruf
Journal:  Clin Investig       Date:  1992-06

9.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

10.  Inhibition of growth of Toxoplasma gondii by qinghaosu and derivatives.

Authors:  O Y Ke; E C Krug; J J Marr; R L Berens
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.